Answers are grounded in this paper and cite their sources.
Prospective observational study shows urinary L-FABP detects acute kidney injury after aortic aneurysm repair, indicating its value as an early postoperative biomarker.
OBJECTIVE To evaluate the role of urinary liver-type fatty acid binding protein (L-FABP) in early detection of acute kidney injury (AKI) after endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). DESIGN Prospective, observational, multicenter study. SETTING Four university hospitals from January 2024 to June 2024. PARTICIPANTS Fifty-nine hospitalized patients with AAA. INTERVENTIONS Patients undergoing EVAR were included. Demographic data, comorbidities, and renal function data were recorded at baseline and after intervention. L-FABP data were collected at baseline and at 6 hours and 24 hours after surgery. MEASUREMENTS AND MAIN RESULTS The cohort had a mean age of 70.2 ± 7.3 years and was predominantly male (84.7%). Positive L-FABP results were observed in 24.1% of patients at 6 hours post-EVAR and in 23.7% at 24 hours post-EVAR. A positive L-FABP status at both time points was significantly associated with elevated postoperative serum creatinine (SCr) and reduced estimated glomerular filtration rate (eGFR) (p ≤ 0.015), reduced urine output (p = 0.009 and p < 0.001), and shorter hospital length of stay (LOS) (p = 0.004 and p = 0.013). Multivariable logistic regression analysis fully confirmed these associations. Predictive models incorporating L-FABP achieved high accuracy for identifying patients with reduced diuresis (up to 86.1%). Additionally, L-FABP at 6 hours and 24 hours predicted LOS, whereas SCr and eGFR values did not. CONCLUSION Urinary L-FABP is emerging as a sensitive biomarker for AKI in patients undergoing EVAR.
No takes yet. Share an insight, caveat, or question.
Abelardo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: